Paula T. Trzepacz
Corporate Officer/Principal at The Indiana University School of Medicine
Paula T. Trzepacz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The Indiana University School of Medicine | Corporate Officer/Principal | 2003-12-31 | - |
Career history of Paula T. Trzepacz
Former positions of Paula T. Trzepacz
| Companies | Position | Start | End |
|---|---|---|---|
| SYNAPTOGENIX, INC. | Chief Tech/Sci/R&D Officer | 2016-06-20 | 2016-08-31 |
| University of Mississippi Medical Center | Corporate Officer/Principal | - | - |
| University of Pittsburgh School of Medicine | Corporate Officer/Principal | - | - |
| NEUROTROPE, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Paula T. Trzepacz
| Wellesley College | Undergraduate Degree |
| Dartmouth College | Doctorate Degree |
Statistics
International
| United States | 8 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SYNAPTOGENIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Paula T. Trzepacz
- Experience
